References
- Brown RB, Phillips D, Barker MJ, Pieczarka R, Sands M, Teres D. Outbreak of nosocomial Flavobacterium meningosepticum respiratory infections associated with use of aerosolized polymixin B. Am J Infect Control 1989; 17: 121–5.
- Bloch KC, Nadarajah R, Jacobs R. Chryseobacterium meningosepticum: An emerging pathogen among immunocompromised adults. Report of 6 cases and literature review. Medicine (Baltimore) 1997; 76: 30–41.
- Sheridan RL, Ryan CM, Pasternack MS, Weber JM, Tompkins RG. Flavobacterial sepsis in massively burned pediatric patients. Clin Infect Dis 1993; 17: 185–7.
- Bolivar R, Abramovits W. Cutaneous infection caused by Flavobacterium meningosepticum. J Infect Dis 1989; 159: 150–1.
- Hoque SN, Graham J, Kaufmann ME, Tabaqchali S. Chryseobacterium (Flavobacterium) meningosepticum outbreak associated with colonization of water taps in a neonatal intensive care unit. J Hosp Infect 2001; 47: 188–92.
- Kienzle N, Muller M, Pegg S. Chryseobacterium in burn wounds. Burns 2001; 27: 179–82.
- Jorgensen JH, Maher LA, Howell AW. Activity of meropenem against antibiotic-resistant or infrequently encountered gramnegative bacilli. Antimicrob Agents Chemother 1991; 35: 2410–4.
- Fraser SL, Jorgensen JH. Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997; 41: 2738–41.
- Scully BE, Neu HC. Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J Antimicrob Chemother 1986; 18 (Suppl D): 179–85.